Owens & Minor (NYSE:OMI) Price Target Cut to $13.00 by Analysts at UBS Group

Owens & Minor (NYSE:OMI) had its target price reduced by UBS Group from $25.00 to $13.00 in a report issued on Thursday,Benzinga reports. UBS Group currently has a buy rating on the stock.

Other equities research analysts have also recently issued research reports about the stock. Barclays lowered their target price on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. Citigroup lowered their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Finally, Robert W. Baird lowered their target price on shares of Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 4th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $16.79.

Owens & Minor Stock Performance

Shares of OMI opened at $7.69 on Thursday. Owens & Minor has a 52-week low of $7.64 and a 52-week high of $28.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The firm’s fifty day moving average is $12.93 and its two-hundred day moving average is $13.91.

Insider Activity

In other news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the transaction, the chief financial officer now owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. The trade was a 3.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 3.59% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of OMI. The Manufacturers Life Insurance Company boosted its position in shares of Owens & Minor by 4.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 36,366 shares of the company’s stock valued at $491,000 after acquiring an additional 1,709 shares during the last quarter. SG Americas Securities LLC purchased a new stake in Owens & Minor in the 3rd quarter valued at about $494,000. Inspire Advisors LLC purchased a new stake in Owens & Minor in the 3rd quarter valued at about $217,000. Blue Trust Inc. raised its holdings in Owens & Minor by 176.8% in the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after buying an additional 1,780 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its holdings in Owens & Minor by 383.9% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 29,376 shares of the company’s stock valued at $461,000 after buying an additional 23,305 shares during the period. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.